Curcumin promotes browning of white adipose tissue in a norepinephrine-dependent way DOI
Shan Wang, Xiuchao Wang, Zichen Ye

и другие.

Biochemical and Biophysical Research Communications, Год журнала: 2015, Номер 466(2), С. 247 - 253

Опубликована: Сен. 11, 2015

Язык: Английский

Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases DOI Open Access
Ajaikumar B. Kunnumakkara, Devivasha Bordoloi, Ganesan Padmavathi

и другие.

British Journal of Pharmacology, Год журнала: 2016, Номер 174(11), С. 1325 - 1348

Опубликована: Сен. 17, 2016

Curcumin, a yellow pigment in the Indian spice Turmeric (Curcuma longa), which is chemically known as diferuloylmethane, was first isolated exactly two centuries ago 1815 by German Scientists, Vogel and Pelletier. However, according to pubmed database, study on its biological activity an antibacterial agent published 1949 Nature clinical trial reported The Lancet 1937. Although current database indicates almost 9000 publications curcumin, until 1990 there were less than 100 papers this nutraceutical. At molecular level, multitargeted has been shown exhibit anti-inflammatory through suppression of numerous cell signalling pathways including NF-κB, STAT3, Nrf2, ROS COX-2. Numerous studies have indicated that curcumin highly potent antimicrobial be active against various chronic diseases types cancers, diabetes, obesity, cardiovascular, pulmonary, neurological autoimmune diseases. Furthermore, compound also synergistic with other nutraceuticals such resveratrol, piperine, catechins, quercetin genistein. To date, over different trials completed clearly show safety, tolerability effectiveness humans. more populations are necessary prove potential This review's primary focus lessons learnt about from trials.

Язык: Английский

Процитировано

910

Antidiabetic Potential of Medicinal Plants and Their Active Components DOI Creative Commons
Bahare Salehi,

Athar Ata,

N. V. Anil Kumar

и другие.

Biomolecules, Год журнала: 2019, Номер 9(10), С. 551 - 551

Опубликована: Сен. 30, 2019

Diabetes mellitus is one of the major health problems in world, incidence and associated mortality are increasing. Inadequate regulation blood sugar imposes serious consequences for health. Conventional antidiabetic drugs effective, however, also with unavoidable side effects. On other hand, medicinal plants may act as an alternative source agents. Examples potential described, focuses on preclinical clinical studies. The beneficial each plant matrix given by combined concerted action their profile biologically active compounds.

Язык: Английский

Процитировано

589

Curcumin, Inflammation, and Chronic Diseases: How Are They Linked? DOI Creative Commons
Yan He, Yuan Yue, Xi Zheng

и другие.

Molecules, Год журнала: 2015, Номер 20(5), С. 9183 - 9213

Опубликована: Май 20, 2015

It is extensively verified that continued oxidative stress and damage may lead to chronic inflammation, which in turn can mediate most diseases including cancer, diabetes, cardiovascular, neurological, inflammatory bowel disease pulmonary diseases. Curcumin, a yellow coloring agent extracted from turmeric, shows strong anti-oxidative anti-inflammatory activities when used as remedy for the prevention treatment of How activates pathways leading progression focus this review. Thus, research date suggests stress, are closely linked, antioxidant properties curcumin play key role inflammation

Язык: Английский

Процитировано

515

The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update DOI
Shatadal Ghosh, Sharmistha Banerjee, Parames C. Sil

и другие.

Food and Chemical Toxicology, Год журнала: 2015, Номер 83, С. 111 - 124

Опубликована: Июнь 13, 2015

Язык: Английский

Процитировано

463

Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies DOI
Hamed Mirzaei, Abolfazl Shakeri, Bahman Rashidi

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2016, Номер 85, С. 102 - 112

Опубликована: Дек. 5, 2016

Язык: Английский

Процитировано

461

Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review DOI
Vahid Soleimani, Amirhossein Sahebkar, Hossein Hosseinzadeh

и другие.

Phytotherapy Research, Год журнала: 2018, Номер 32(6), С. 985 - 995

Опубликована: Фев. 26, 2018

Curcumin is the major constituent of turmeric ( Curcuma longa ). Turmeric has been widely used as a spice in foods and for therapeutic applications such anti‐inflammatory, antihyperlipidemic, antimicrobial activities. curcumin are nonmutagenic nongenotoxic. Oral use did not have reproductive toxicity animals at certain doses. Studies on human show toxic effects, was safe dose 6 g/day orally 4–7 weeks. However, some adverse effects gastrointestinal upsets may occur. Moreover, oral bioavailable formulations were 500 mg two times day 30 days, but there still few trials more studies needed specially nanoformulations it should be discussed separate article. In addition, known generally recognized substance. This review discusses safety medicine. nontoxic especially administration. also animals. They pregnancy needed.

Язык: Английский

Процитировано

457

Cellular and molecular mechanisms of curcumin in prevention and treatment of disease DOI

Sita Sharan Patel,

Ashish Acharya,

R. S. Ray

и другие.

Critical Reviews in Food Science and Nutrition, Год журнала: 2019, Номер 60(6), С. 887 - 939

Опубликована: Янв. 11, 2019

Curcumin is a naturally occurring polyphenolic compound present in rhizome of Curcuma longa belonging to the family zingiberaceae. Growing experimental evidence revealed that curcumin exhibit multitarget biological implications signifying its crucial role health and disease. The current review highlights recent progress mechanisms underlying wide range pharmacological effects against numerous diseases like neuronal, cardiovascular, metabolic, kidney, endocrine, skin, respiratory, infectious, gastrointestinal cancer. ability modulate functions multiple signal transductions are linked with attenuation acute chronic diseases. Numerous preclinical clinical studies have modulates several molecules cell transduction pathway including PI3K, Akt, mTOR, ERK5, AP-1, TGF-β, Wnt, β-catenin, Shh, PAK1, Rac1, STAT3, PPARγ, EBPα, NLRP3 inflammasome, p38MAPK, Nrf2, Notch-1, AMPK, TLR-4 MyD-88. has potential prevent and/or manage various due anti-inflammatory, anti-oxidant anti-apoptotic properties an excellent safety profile. In contrast, anti-cancer reflected induction growth arrest apoptosis premalignant malignant cells. This also carefully emphasized pharmacokinetics interaction other drugs. Clinical shown safe at doses 12 g/day but exhibits poor systemic bioavailability. use adjuvant piperine, liposomal curcumin, nanoparticles phospholipid complex enhanced bioavailability therapeutic potential. Further warranted prove ailments.

Язык: Английский

Процитировано

381

Therapeutic and Medicinal Uses of Terpenes DOI

Destinney Cox-Georgian,

Niveditha Ramadoss,

Chathu Dona

и другие.

Springer eBooks, Год журнала: 2019, Номер unknown, С. 333 - 359

Опубликована: Янв. 1, 2019

Язык: Английский

Процитировано

324

Dietary polyphenols as antidiabetic agents: Advances and opportunities DOI Creative Commons
Chongde Sun, Chao Zhao, Esra Çapanoğlu

и другие.

Food Frontiers, Год журнала: 2020, Номер 1(1), С. 18 - 44

Опубликована: Март 1, 2020

Abstract Dietary polyphenols have been widely investigated as antidiabetic agents in cell, animals, human study, and clinical trial. The number of publication (Indexed by Web Science) on “polyphenols diabetes” significantly increased since 2010. This review highlights the advances opportunities dietary agents. prevent manage Type 2 diabetes mellitus via insulin‐dependent approaches, for instance, protection pancreatic islet β‐cell, reduction β‐cell apoptosis, promotion proliferation, attenuation oxidative stress, activation insulin signaling, stimulation pancreas to secrete insulin, well insulin‐independent approaches including inhibition glucose absorption, digestive enzymes, regulation intestinal microbiota, modification inflammation response, formation advanced glycation end products. Moreover, ameliorate diabetic complications, such vascular dysfunction, nephropathy, retinopathy, neuropathy, cardiomyopathy, coronary diseases, renal failure, so on. structure–activity relationship is still not clear. individual flavonoid or isoflavone has no therapeutic effect patients, although data are very limited. Resveratrol, curcumin, anthocyanins showed activity study. How hyperglycemia influences bioavailability bioactivity understood. An understanding how alters will lead an improvement their benefits outcomes.

Язык: Английский

Процитировано

254

In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature DOI Open Access

Guangjiang Shi,

Yan Li,

Qiuhua Cao

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2018, Номер 109, С. 1085 - 1099

Опубликована: Ноя. 6, 2018

Quercetin, a typical flavonoid, possesses diverse biochemical and physiological actions, including antiplatelet, estrogenic, anti-inflammatory properties. This review mainly centers on recent ten years findings with respect to intervening diabetes its complications the well-known flavonoid quercetin. After short introduction of quercetin, major in vitro vivo are summarized showing that quercetin is promising molecule for treatment these diseases. Finally, we contemplate future development application prospects Despite wealth animal research results suggesting anti-diabetic potential efficacy diabetic human subjects yet be explored. The problem may become an important direction research.

Язык: Английский

Процитировано

251